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Abstract
Apart from bat-SARS-CoV, we have identified a novel group 1 coronavirus, bat-CoV HKU2, in Rhinolophus sinicus (Chinese horseshoe bats).
Since it has been suggested that the receptor-binding motif (RBM) of SARS-CoV may have been acquired from a group 1 coronavirus, we
conducted a surveillance study and identified bat-SARS-CoV and bat-CoV HKU2 in 8.7% and 7.5% respectively of R. sinicus in Hong Kong and
Guangdong. Complete genome sequencing of four strains of bat-CoV HKU2 revealed the smallest coronavirus genome (27164 nucleotides) and a
unique spike protein evolutionarily distinct from the rest of the genome. This spike protein, sharing similar deletions with other group 2
coronaviruses in its C-terminus, also contained a 15-amino acid peptide homologous to a corresponding peptide within the RBM of spike protein
of SARS-CoV, which was absent in other coronaviruses except bat-SARS-CoV. These suggest a common evolutionary origin in the spike protein
of bat-CoV HKU2, bat-SARS-CoV, and SARS-CoV.
© 2007 Elsevier Inc. All rights reserved.Keywords: Chinese horseshoe bats; Coronavirus; HKU2; SARS; Novel; Receptor; OriginIntroduction
Coronaviruses can infect a wide variety of animals in which
they can cause respiratory, enteric, hepatic and neurological
diseases of varying severity. Based on genotypic and serological
characteristics, coronaviruses were classified into three distinct
groups (Brian and Baric, 2005; Lai and Cavanagh, 1997;
Ziebuhr, 2004). As a result of the unique mechanism of viral
replication, coronaviruses have a high frequency of recombina-
tion (Lai and Cavanagh, 1997). Such a high recombination rate,⁎ Corresponding author. State Key Laboratory of Emerging Infectious
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423, University Pathology Building, Queen Mary Hospital, Hong Kong. Fax:
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doi:10.1016/j.virol.2007.06.009coupled with the infidelity of the polymerases of RNA viruses,
may allow them to adapt to new hosts and ecological niches
(Herrewegh et al., 1998; Woo et al., 2006c).
The severe acute respiratory syndrome (SARS) epidemic in
2003, caused by a novel coronavirus, SARS coronavirus
(SARS-CoV), has aroused interests in the discovery of novel
coronaviruses in both humans and animals (Guan et al., 2003;
Marra et al., 2003; Peiris et al., 2003; Rota et al., 2003; Woo et
al., 2004). Before that, only 19 (two human, 13 mammalian and
four avian) coronaviruses were known. After the epidemic, two
novel human coronaviruses, human coronavirus NL63 (HCoV-
NL63), a group 1 coronavirus, and coronavirus HKU1 (CoV-
HKU1), a group 2 coronavirus, have been discovered (Fouchier
et al., 2004; Lau et al., 2006; van der Hoek et al., 2004; Woo et
al., 2005a, 2005b). In the recent two years, at least 10 previously
unrecognized coronaviruses from bats were also described in
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2005b; Poon et al., 2005; Tang et al., 2006; Woo et al., 2006a,
2006d), suggesting that bats play an important role in the
ecology and evolution of coronaviruses.
Although the identification of SARS-CoV-like viruses in
Himalayan palm civets and raccoon dogs in live-animal markets
in southern China suggested that wild animals could be the
origin of SARS (Guan et al., 2003), the absence of related
viruses in wild civets in extensive surveillance studies and the
rapid evolution of SARS-CoV genomes in market civets
suggested that these caged animals were likely only intermediate
hosts and there is a yet unidentified natural reservoir for SARS-
CoV (Li et al., 2005a; Song et al., 2005; Tu et al., 2004; Yang et
al., 2005). Recently, we have described the discovery of a SARS-
CoV-like virus, bat SARS coronavirus (bat-SARS-CoV), in
Chinese horseshoe bats in Hong Kong (Lau et al., 2005). Similar
viruses have also been found in other species of horseshoe bats in
mainland China (Li et al., 2005b), suggesting that horseshoe bats
are reservoir of SARS-CoV-like viruses. However, genome
sequence comparison of SARS-CoV-like coronaviruses from
horseshoe bats and human/civet SARS-CoV showed that they
shared only 88–92% nucleotide identities.More importantly, the
amino acid sequence identities between the spike (S) proteins of
bat and human/civet viruses were only 78–80% (Lau et al.,
2005; Li et al., 2005b; Ren et al., 2006). Therefore, events such
as mutation and/or recombination would have occurred during
the evolution of these SARS-CoV-like viruses before the
possible emergence of direct progenitors of SARS-CoV capable
of infecting palm civets and subsequently humans.
In a recent report on angiotensin-converting enzyme 2
(ACE2)–S protein interactions of SARS-CoV, it was suggested
that the receptor-binding motif (RBM) of SARS-CoV may have
been acquired from a group 1 virus related to HCoV-NL63 (Li et
al., 2006). Interestingly, a novel group 1 coronavirus, bat
coronavirus HKU2 (bat-CoV HKU2), was identified in Chinese
horseshoe bats in addition to bat-SARS-CoV in our previous
surveillance studies (Lau et al., 2005; Woo et al., 2006d). To
better understand the epidemiology and evolution of bat-CoV
HKU2 and explore possible recombination events between this
group 1 coronavirus and bat-SARS-CoV that could have led to
the emergence of SARS-CoV, we conducted an extensive
surveillance for coronaviruses in Chinese horseshoe bats in
Hong Kong and Guangdong, the province in southern China
where the SARS epidemic originated, over a 2-year period. Four
complete genomes of bat-CoV HKU2, three from Hong Kong
and one from Guangdong, were also sequenced and analyzed.
Comparison of bat-CoV HKU2 genomes with other coronavirus
genomes revealed a spike protein distinct from the spike proteins
of other group 1 coronaviruses, with a peptide homologous to a
segment of the RBM of the S protein of SARS-CoV.
Results
Coronavirus surveillance in Chinese horseshoe bats
A total of 770 respiratory and alimentary specimens from
348 and 64 Chinese horseshoe bats were obtained in HongKong and in the Guangdong province in Southern China,
respectively. RT-PCR for a 440-bp fragment in the RdRp genes
of coronaviruses was positive in alimentary specimens from 58
(16.7%) of the 348 bats from Hong Kong, and from 8 (12.5%)
of the 64 bats from Guandong. None of the respiratory
specimens was positive. Sequencing results suggested the
presence of two different coronaviruses among the 64 positive
bats. Of the 58 positive bats from Hong Kong, the sequences of
29 samples possessed ≥99% nucleotide identities to bat-CoV
HKU2 (GenBank accession no. DQ249235), while those of the
other 29 samples possessed ≥99% nucleotide identities to bat-
SARS-CoV (GenBank accession no. DQ022305) (Lau et al.,
2005; Woo et al., 2006d). The bats positive for bat-CoV HKU2
and bat-SARS-CoV were from nine of the 18 sampling
locations in Hong Kong, with bats from three locations
harboring both viruses (Fig. 1). Of the eight positive bats
from Guangdong, the sequences of six alimentary samples
possessed 97–98% nucleotide identities to bat-CoV HKU2,
while that of one possessed 98% nucleotide identities to bat-
SARS-CoV. The remaining positive sample contained both bat-
CoV HKU2 and bat-SARS-CoV with 98% nucleotide iden-
tities. Attempts to stably passage bat-CoV HKU2 in cell lines
were unsuccessful.
Characterization of bat-CoV HKU2 genomes
Complete genome sequence data of four strains of bat-CoV
HKU2 were obtained by assembly of the sequences of the RT-
PCR products obtained directly from four individual specimens
collected at different time and places. Three strains were
obtained from Hong Kong (bat-CoV HKU2/HK/33/2004, bat-
CoV HKU2/HK/298/2004 and bat-CoV HKU2/HK/46/2006)
(Fig. 1), while one was obtained from Guangdong (bat-CoV
HKU2/GD/430/2006). Their genomes were 27,164-nucleotide,
polyadenylated RNA, the smallest genome size among all
coronaviruses with genome sequences available (Table 1 and
Fig. 2). The G+C content was 39% (Table 1). The four strains
share the same genome structures and were highly similar in
their nucleotide sequence. The three Hong Kong strains were
more closely related to each other with 99.9% overall nucleotide
identities, while that from Guangdong had 98.5% nucleotide
identities with the three Hong Kong strains. Their genome
organization was similar to other coronaviruses (Table 2 and
Fig. 2). Bat-CoV HKU2 possessed the putative transcription
regulatory sequence (TRS) motif, 5′-AACUAAA-3′, at the 3′
end of the leader sequence and precedes each ORF (Table 2).
This TRS has also been shown to be the TRS for HCoV-NL63
(Pyrc et al., 2004), whereas a shorter sequence, 5″-CUAAAC-
3′, was found to be the TRS for other group 1 coronaviruses
such as TGEV and FIPV (Dye and Siddell, 2005; Hiscox et al.,
1995).
Similar to other coronaviruses, the replicase ORF1ab
encodes a number of putative proteins, including nsp3 [which
contains the putative papain-like protease (PLpro)], nsp5
[putative chymotrypsin-like protease (3CLpro)], nsp12 (putative
RdRp), nsp13 [putative helicase (Hel)], which are produced by
proteolytic cleavage by PLpro and 3CLpro at specific sites (Woo
Fig. 1. Map showing locations of sampling in Hong Kong. Dark circles represent locations positive for bat-CoV HKU2, squares represent locations positive for bat-
SARS-CoV, and triangles represent locations positive for both bat-CoV HKU2 and bat-SARS-CoV. Blank circles represent locations negative for bat-SARS-CoVand
bat-CoV HKU2. Location Awas where bat-CoV HKU2/HK/33/2004 was found, location B was where bat-CoV HKU2/HK/298/2004 was found, and location C was
where bat-CoV HKU2/HK/46/2006 was found.
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genome of bat-CoV HKU2 has two putative PLpro, which are
homologous to PL1pro and PL2pro of other group 1 corona-
viruses (Fig. 2).
One ORF, which encodes a putative 229-amino acid
nonstructural protein, NS3, was observed between the S and
E genes. This NS3 possessed 42% amino acid identities to the
NS3 of HCoV-NL63, 37% identities to that of BtCoV/512/05,
36% identities to that of PEDV, and 29% identities to the NS3b
of TGEV. No functional domains were identified by PFAM and
InterProScan. TMHMM analysis showed three putative trans-
membrane domains in NS3 of bat-CoV HKU2 (residues 38–60,
81–103, and 118–140).
The most striking feature of bat-CoV HKU2 genome was
observed in its S protein which possessed the shortest amino
acid sequence (1128 amino acid residues) among the S proteins
of all coronaviruses, as a result of deletions in the N-terminal
region (Supplementary Fig. 1). It had ≤27% amino acid
identities to the S proteins of all known coronaviruses, as
opposed to other genes which showed higher amino acid
identities to the corresponding genes in other group 1
coronaviruses (especially group 1b) than to group 2 and
group 3 coronaviruses (Table 1). When the S protein of bat-CoV
HKU2 is aligned with the S protein of other group 1
coronaviruses, many of the amino acid residues conserved
among and specific to group 1b coronaviruses were not found;whereas residues conserved among all coronaviruses, especially
those in the C-terminal region, were identified (Supplementary
Fig. 1). In fact, the N-terminal region of the S protein of bat-
CoV HKU2 possessed very low amino acid identities to the
corresponding regions in any group of coronaviruses, which
was due to both amino acid substitutions and deletions. Despite
this, a short peptide consisting of 15 amino acids (residues 314
to 328) was found to be homologous to a corresponding peptide
within the RBM in the S1 domain of SARS-CoV (residues 437
to 451) (Fig. 3). A similar peptide was also observed in bat-
SARS-CoV, but not in any other known coronaviruses,
suggesting that it is specific to SARS-CoV, bat-SARS-CoV
and bat-CoV HKU2, with a common origin. Of the 15 amino
acids within this homologous peptide, six (tyrosine 438, leucine
442, glycine 445, lysine 446, proline 449, and phenylalanine
450) were conserved between SARS-CoVand bat-CoV HKU2,
with four using identical codons. Of these six amino acid
residues, only four (tyrosine 438, lysine 446, proline 449, and
phenylalaine) were found in bat-SARS-CoV, with two using
identical codons. On the other hand, four additional amino acid
residues (tyrosine 439, arginine 440, arginine 443, and leucine
447), not found in bat-CoV HKU2, were conserved between
SARS-CoV and bat-SARS-CoV, though with different codon
usage. In contrast to a previous study which suggested that the
extended receptor-binding domain of HCoV-NL63 includes a
stretch of residues with weak homology to the RBM of SARS-
Table 1
Comparison of genomic features of bat-CoV HKU2 and other coronaviruses and amino acid identities between the predicted 3CLpro, RdRp, Hel, S, E, M, and N
proteins of bat-CoV HKU2 and the corresponding proteins of other coronaviruses
Coronaviruses a Genome Features Pairwise amino acid identity (%)
Size (bases) G+C content 3CLpro RdRp Hel S E M N
Group 1a
TGEV 28586 0.38 63.2 75.8 77.5 21.9 28.9 47.3 40.3
FIPV 29355 0.38 61.3 75.9 77.6 22.3 28.9 45.5 41.6
PRCV 27550 0.37 62.9 75.6 77.3 26.0 30.1 47.5 40.0
Group 1b
HCoV-229E 27317 0.38 64.2 81.2 81.1 27.0 51.3 56.5 44.5
HCoV-NL63 27553 0.34 64.0 79.4 81.6 25.7 50.0 59.6 46.8
PEDV 28033 0.42 65.2 78.5 78.4 24.0 46.2 64.8 39.6
BtCoV/512/2005 28203 0.40 62.3 77.8 78.2 25.9 50.0 61.3 46.9
Bat-CoV HKU6 NAb NA NA 77.9 78.2 NA NA NA NA
Bat-CoV HKU7 NA NA NA 82.7 80.6 NA NA NA 46.3
Bat-CoV HKU8 NA NA NA 80.7 81.6 NA NA NA 48.7
Bat-CoV 1A (partial CDS) NA NA NA 80.0 NA NA NA NA 50.5
Bat-CoV 1B (partial CDS) NA NA NA 80.0 NA NA NA NA 50.2
Bat-CoV HKU2 27164 0.39 – – – – – – –
Group 2a
CoV-HKU1 29926 0.32 45.5 56.6 53.6 24.5 30.4 34.3 27.8
HCoV-OC43 30738 0.37 44.2 57.4 54.5 24.1 32.3 36.6 24.7
MHV 31357 0.42 46.9 56.3 54.2 24.8 28.6 36.5 26.9
BCoV 31028 0.37 44.2 57.3 54.6 23.4 32.3 36.3 23.9
PHEV 30480 0.37 43.9 57.2 54.5 24.5 33.3 35.7 24.7
Group 2b
SARS-CoV 29751 0.41 43.5 59.9 61.3 25.6 27.3 30.7 22.4
Bat-SARS-CoV HKU3 29728 0.41 43.8 59.8 60.8 25.9 27.3 31.2 22.4
Group 2c
Bat-CoV HKU4 30286 0.38 47.7 59.4 61.8 23.6 22.6 33.9 26.3
Bat-CoV HKU5 30488 0.43 46.6 58.7 61.8 23.5 25.3 30.6 26.4
Group 2d
Bat-CoV HKU9 29114 0.41 45.6 58.0 61.8 25.5 23.8 34.2 19.3
Group 3
IBV 27608 0.38 40.1 58.5 56.1 24.2 18.9 22.7 22.1
a TGEV, porcine transmissible gastroenteritis virus; FIPV, feline infectious peritonitis virus; PRCV, porcine respiratory coronavirus; HCoV-229E, human
coronavirus 229E; HCoV-NL63, human coronavirus NL63; PEDV, porcine epidemic diarrhea virus; CoV-HKU1, coronavirus HKU1; HCoV-OC43, human
coronavirus OC43; MHV, murine hepatitis virus; BCoV, bovine coronavirus; PHEV, porcine hemagglutinating encephalomyelitis virus; SARS-CoV, SARS
coronavirus; bat-SARS-CoV HKU3, bat SARS coronavirus HKU3; IBV, infectious bronchitis virus.
b NA, data not available for analysis.
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group of researchers did not identify any significant homology
between the spike protein of the two coronaviruses (Hofmann et
al., 2006). When compared to the S proteins of other group 1
coronaviruses and SARS-CoV, large deletions were observed in
the S protein of bat-CoV HKU2 in the region corresponding to
the RBM of SARS-CoV. Since the amino acid sequence of the S
protein of bat-SARS-CoV also differed significantly from that
of SARS-CoV in this region, it is likely that this is a site of
frequent mutation and/or recombination among coronaviruses
in Chinese horseshoe bats. This highly variable region within
the S protein of bat-CoV HKU2 and bat-SARS-CoV may have
been important for host receptor adaptation. Although the
overall amino acid identities of the S protein of bat-CoV HKU2
were equally low when compared to the S proteins of all three
groups of coronaviruses, the S protein of bat-CoV HKU2 shares
the two conserved regions of deletions both of 14 amino acids
among group 2 coronaviruses in its C-terminus (Supplementary
Fig. 1). This suggests that this segment of the S protein of bat-
CoV HKU2 may have co-evolved with the correspondingregions in group 2 coronaviruses. Nevertheless, the receptor for
bat-CoV HKU2 remains to be determined. Aminopeptidase N
(CD13) has been shown to be the receptor for many group 1
coronaviruses including HCoV-229E, canine coronavirus,
FIPV, PEDV, and TGEV (Delmas et al., 1992; Yeager et al.,
1992). As for group 2 coronaviruses, carcinoembryonic
antigen-cell adhesion molecule 1 (CEACAM1) was identified
as the receptor for murine hepatitis virus (MHV), while sialic
acids were found to be the receptor for bovine coronavirus
(BCoV) and human coronavirus OC43 (HCoV-OC43) (Krempl
et al., 1995; Williams et al., 1991). However, human ACE2
(hACE2) have been shown to be the receptor for both SARS-
CoV, a group 2 coronavirus, and HCoV-NL63, a group 1
coronavirus, although the two viruses utilize different binding
sites for receptor recognition (Hofmann et al., 2005; Li et al.,
2003). The S protein of bat-CoV HKU2 does not exhibit
significant homology to the known receptor binding domains of
HCoV-229E, HCoV-NL63, or MHV (Bonavia et al., 2003;
Hofmann et al., 2006; Kubo et al., 1994). Further experiments
are required to delineate the receptor for bat-CoV HKU2.
Fig. 2. Genome organizations of bat-CoV HKU2 compared to representative coronaviruses from each group. The conserved functional domains ORF 1ab and the
structural proteins are represented by gray boxes. The genome sizes (bp) are shown on the right.
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ORF that encodes a 99-amino acid nonstructural protein, NS7a.
BLAST search revealed no amino acid similarities between this
putative nonstructural protein and other known proteins and no
functional domain was identified by PFAM and InterProScan.
TMHMM analysis showed two putative transmembrane
domains in NS7a (residues 4–26 and 59–81). Previously,
FIPV and TGEV, both group 1a coronavirus, were the only
coronaviruses known to possess genes downstream of N (Fig.
1). It has been suggested that the two genes downstream of N in
FIPV may be important for virulence (Haijema et al., 2004;
Olsen, 1993). In TGEV, the gene downstream of N has been
suggested to play a role in membrane association of replication
complexes or assembly of the virus (Tung et al., 1992). In our
recent report on the discovery of bat coronavirus HKU9, a novel
bat coronavirus belonging to group 2d coronaviruses, two ORFsdownstream to N were also found (Woo et al., 2006a). In
another group 1b coronavirus recently identified from bats in
China, BtCoV/512/05, an ORF downstream to N was also
identified (Tang et al., 2006). These suggest that ORFs
downstream to N can be present in coronaviruses other than
group 1a and may be more prevalent among bat coronaviruses.
Further experiments will delineate the function of such ORFs in
bat coronaviruses.
Phylogenetic analyses
The phylogenetic trees constructed using the amino acid
sequences of the 3CLpro, RdRp, Hel, S, M, and N of bat-CoV
HKU2 and other coronaviruses are shown in Fig. 4 and the
corresponding pairwise amino acid identities are shown in Table
1. As shown in all six trees, the four strains of bat-CoV HKU2
Table 2
Coding potential and putative transcription regulatory sequences of bat-CoV HKU2
Coronaviruses ORFs Start-end
(nucleotide position)
No. of
nucleotides
No. of
amino acids
Frame Putative TRS
Nucleotide position in genome TRS sequence
Bat-CoV HKU2 1ab 297–20,479
(shift at 12,446)
20,183 6727 +3/+2 122 AACUAAAC(167)AUG
S 20,476–23,862 3387 1128 +1 20,470 AACUAAAUG
NS3 23,862–24,551 690 229 +3 23,817 AACUAAAC(37)AUG
E 24,532–24,759 228 75 +1 24,523 AACUAAAC(1)AUG
M 24,768–25,457 690 229 +3 24,754 AACUAAAC(6)AUG
N 25,469–26,596 1128 375 +2 25,452 AACUAAAC(9)AUG
NS7a 26,608–26,907 300 99 +1 26,600 AACUAAACAUG
433S.K.P. Lau et al. / Virology 367 (2007) 428–439were clustered together, reflecting their high sequence simila-
rities. For all the genes except S, bat-CoV HKU2 formed a
distinct branch that clustered with other group 1 coronaviruses.
This is supported by the higher amino acid identities to the
corresponding genes in other group 1 coronaviruses (especially
group 1b) than to those of group 2 and group 3 coronaviruses
(Table 1). However, for the S gene, bat-CoV HKU2 formed a
branch distinct from the three groups of known coronaviruses.
The same tree topology was obtained when using the maximum
likelihood method and Bayesian approach (data not shown).
This finding is in line with results obtained from pairwise amino
acid comparisons, which showed that the S of bat-CoV HKU2
possessed equally low amino acid identities (≤27%) to the S of
all three groups of coronaviruses (Table 1).
Recombination analysis
To evaluate if segments of the SARS-CoV genome have
arisen as a result of recombination between bat-SARS-CoVand
bat-CoV HKU2, a sliding window analysis was conducted. No
statistical support for recombination was obtained, which may
be due to the high sequence divergence between the bat-SARS-
CoV and bat-CoV HKU2 genomes.
Estimation of synonymous and non-synonymous substitution
rates
The Ka/Ks ratios for the various coding regions in bat-CoV
HKU2 are shown in Table 3. Higher Ka/Ks ratios were observed
within ORF1ab, especially nsp3 (which encodes the putative
PLpro domains), nsp5 (which encodes the putative 3CLpro), and
nsp14 (which encodes the helicase), whereas the ratios appeared
to be lower among the structural genes. Notably, the Ka/Ks ratioFig. 3. A short stretch of peptide within the RBM of S protein of SARS-CoV with ho
CoV. The conserved amino acids are in bold and boxed.for the S of bat-CoV HKU2 is only 0.03, suggesting that this
gene is unlikely undergoing rapid evolution under positive
selection.
Discussion
In this study, bat-CoV HKU2 was found among 29 (8.3%) of
348 Chinese horseshoe bats from Hong Kong and 7 (10.9%) of
64 bats from Guangdong. All bats infected with bat-CoV HKU2
appeared healthy. The finding that bat-CoV HKU2 can only be
detected in alimentary specimens suggests that it possesses
enteric tropism. The genomes of the four strains of bat-CoV
HKU2 being sequenced were highly similar, with conserved
nucleotide and amino acid sequences in most of their genes
(Fig. 4). Traditionally, coronaviruses have been classified into
groups 1, 2, and 3. Based on a comprehensive comparative
analysis of the genomes of the various groups of coronaviruses,
coronaviruses can be classified into group 1 (subgroups 1a and
1b), group 2 (subgroups 2a, 2b, 2c, and 2d) and group 3 (Woo et
al., 2006a), with SARS-CoV being classified as group 2b
coronaviruses (Eickmann et al., 2003; Snijder et al., 2003).
Comparative amino acid sequence analysis showed that the
predicted proteins in bat-CoV HKU2, except the S protein, were
most similar to subgroup 1b of group 1 coronaviruses than to
other groups of coronaviruses (Table 1). Based on phylogenetic
analysis of the 3CLpro, RdRp, Hel, M, and N genes, the four
strains of bat-CoV HKU2 formed a distinct branch within
subgroup 1b of group 1 coronaviruses. They also possessed
genomic features most similar to other members within this
subgroup (Fig. 2). The genomes of group 1a coronaviruses
encode two to three nonstructural proteins between S and E,
whereas most group 1b coronaviruses encode only one such
protein, except HCoV-229E which encodes two (Thiel et al.,mology to the corresponding region in the S of bat-CoV HKU2 and bat-SARS-
Fig. 4. Phylogenetic analysis of 3CLpro, RdRp, Hel, S, M, and N of bat-CoV HKU2. The trees were constructed by neighbor joining method using Kimura's two-
parameter correction and bootstrap values calculated from 1000 trees. 306, 949, 609, 1758, 270, and 586 amino acid positions in 3CLpro, RdRp, Hel, S, M, and N,
respectively, were included in the analysis. The scale bar indicates the estimated number of substitutions per 10 amino acids. HCoV-229E, human coronavirus 229E;
PEDV, porcine epidemic diarrhea virus; TGEV, porcine transmissible gastroenteritis virus; FIPV, feline infectious peritonitis virus; HCoV-NL63, human coronavirus
NL63; CoV-HKU1, coronavirus HKU1; HCoV-OC43, human coronavirus OC43; MHV, murine hepatitis virus; BCoV, bovine coronavirus; PHEV, porcine
hemagglutinating encephalomyelitis virus; IBV, infectious bronchitis virus; SARS-CoV, SARS coronavirus; bat-SARS-CoV HKU3, bat-SARS-like coronavirus
HKU3; bat-CoV HKU4, bat coronavirus HKU4; bat-CoV HKU5, bat coronavirus HKU5; bat-CoV HKU9, bat coronavirus HKU9.
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Table 3
Estimation of non-synonymous substitution and synonymous rates in the
genomes of bat-CoV HKU2
Coding regions Ka/Ks
Bat-CoV HKU2
nsp1 0.197
nsp2 0.105
nsp3 0.470
nsp4 0.059
nsp5 0.320
nsp6 0.133
nsp7 Ka=0, Ks=0.01925
nsp8 0.855
nsp9 Ka=0, Ks=0.00864
nsp10 Ka=0, Ks=0
nsp11 Ka=0, Ks=0
nsp12 0.037
nsp13 0.027
nsp14 0.338
nsp15 0.178
nsp16 Ka=0.00071, Ks=0
S 0.030
NS3 0.194
E 0.098
M 0.148
N 0.076
NS7a Ka=0, Ks=0.01847
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similar to Bt/CoV/512/05, a recently reported bat coronavirus
from Scotophilus kuhlii in China, contains a small ORF
downstream to the N gene, which is not observed in other
group 1b coronaviruses. These results support that bat-CoV
HKU2 represents a novel member within subgroup 1b of group
1 coronaviruses.
The S protein of bat-CoV HKU2 possesses several unique
features. First, it represents the shortest S protein among the S
proteins of known coronaviruses, as a result of substantial
deletions especially in the N-terminal region corresponding to
the RBM of SARS-CoV. These deletions within the S protein
were also largely responsible for the smallest coronavirus
genome observed among all coronaviruses. Second, although
comparative genome analysis strongly suggests that bat-CoV
HKU2 belonged to group 1b coronaviruses, its S protein is not
closely related to the S proteins of any known coronaviruses.
The S proteins of coronaviruses, being responsible for receptor
binding and host species adaptation, are known to be one of the
most variable regions within coronavirus genomes. Never-
theless, S proteins of coronaviruses within the same group or
subgroup are more closely related among themselves than to
members from a different group or subgroup, as shown in the
same cluster upon phylogenetic analysis (Fig. 4). As demon-
strated in a previous study, the within-group amino acid
similarities of the S proteins of coronaviruses ranged from 59 to
91% while between-group similarities were from 22 to 36%
(Tang et al., 2006). In particular, the within-group similarity of
the S proteins of group 1 coronavirus was found to be 59%. In
contrast, the S protein of bat-CoV HKU2 possessed ≤27%
amino acid identities to the S proteins of any knowncoronaviruses and formed a distinct branch away from the
three groups of coronaviruses on phylogenetic analysis,
suggesting that this gene had a very different phylogenetic
position and hence evolutionary history as compared to other
regions within the genome of bat-CoV HKU2. This virus would
have either acquired this unique S protein from a yet
unidentified coronavirus through recombination, or undergone
rapid evolution in its S protein because of strong selective
pressure. Since the Ka/Ks ratio for the S gene of bat-CoV
HKU2 was found to be low when using the four strains
collected from different sites and dates (Table 3), the latter
hypothesis would be less supported. Moreover, further analysis
revealed a unique short peptide with significant homology to a
corresponding peptide within the RBM of SARS-CoV, which
was not seen in any other coronaviruses except bat-SARS-CoV.
The C-terminus of the S protein of bat-CoV HKU2 also
contained regions of deletions conserved among group 2
coronaviruses. Therefore, the S protein of bat-CoV HKU2 is
likely to share a common origin with other group 2 corona-
viruses, especially group 2b coronaviruses, although bat-CoV
HKU2 belongs to group 1 coronaviruses. This suggests that the
S of bat-CoV HKU2 could have been acquired from a group 2
or related coronavirus by recombination. Although recombina-
tion between different groups of coronaviruses has not been
reported previously, targeted recombination between MHVand
it has been proposed that recombination may have occurred
between influenza C virus and coronavirus (Luytjes et al.,
1988). Since the hemagglutinin esterase (HE), a unique protein
only found in group 2 but not in group 1 or 3 coronaviruses,
shared 30% amino acid homology to the hemagglutinin
protein of influenza C virus, it was suggested that the HE of
group 2 coronaviruses could have been acquired from
influenza C virus by their ancestor through recombination.
The present data suggest that the S protein of bat-CoV HKU2,
bat-SARS-CoV, and SARS-CoV could have originated from
an unknown ancestor coronavirus and was thereafter sepa-
rately evolved, with the 15-amino acid homologous region
being left-in molecular signatures. Further studies are required
to elucidate the possible common ancestor virus and its host
species.
Although it remains to be determined if bats are reservoir for
the direct precursor of SARS-CoV, Chinese horseshoe bats are a
potential mixing vessel for the generation of new coronavirus
variants. Apart from bat-CoV HKU2, bat-SARS-CoV was also
found among 29 (8.3%) Chinese horseshoe bats from Hong
Kong and 2 (3.1%) bats from Guangdong in the present study.
Coinfection by both bat-CoV HKU2 and bat-SARS-CoV was
also found in one bat from China. In our previous study, bat-
CoV HKU2 was also detected in a bat positive for antibodies
against bat-SARS-CoV (Lau et al., 2005). Recombination, a
characteristic feature of coronaviruses, has been observed
between both different strains of the same coronavirus species
and different species of coronaviruses. Recombination between
different strains of coronaviruses was first recognized in MHV,
which has been utilized as a valuable molecular tool in the
generation of mutants by targeted RNA recombination (Keck et
al., 1988). Similar phenomenon was subsequently demonstrated
436 S.K.P. Lau et al. / Virology 367 (2007) 428–439in other coronaviruses such as infectious bronchitis virus, a
group 3 coronavirus and between MHV and BCoV, both being
group 2 coronaviruses (Kottier et al., 1995; Lavi et al., 1998).
Recently, by complete genome analysis of 22 strains of CoV-
HKU1, we have also documented for the first time natural
recombination events in a human coronavirus giving rise to at
least three different genotypes (Woo et al., 2006c). Recombina-
tion between two different species of coronavirus, feline
coronavirus type I and canine coronavirus, has also been
suggested to be responsible for generation of feline corona-
virus type II (Herrewegh et al., 1998). Although the existing
data did not provide enough evidence for recombination
between bat-CoV HKU2 and bat-SARS-CoV in the generation
of SARS-CoV, their co-infection of the same bat species
would allow ample opportunities for recombination and
emergence of other SARS-CoV-like viruses capable of inter-
species transmission.
The role of bats in the evolution and ecology of corona-
viruses is yet to be explored. The existence of coronaviruses in
bats was unknown until after the SARS epidemic when we first
identified a novel group 1 coronavirus and bat-SARS-CoV
from bats in Hong Kong (Lau et al., 2005; Poon et al., 2005).
An astonishing diversity of coronaviruses was subsequently
found among the bat population in Hong Kong and other parts
of China (Li et al., 2005b; Tang et al., 2006; Woo et al., 2006a,
2006d). Since bats are commonly found and served in wild
animal markets and restaurants in Guangdong (Woo et al.,
2006b), and given their species diversity, roosting behavior,
and migrating ability, these animals could well be the source
for emergence of zoonotic epidemics like SARS. In a previous
study, it has been suggested that there was species-specific host
restriction of coronavirus in bats, with most coronaviruses from
a single bat species clustered together (Tang et al., 2006).
However, there is evidence that one bat species can be infected
by more than one coronavirus species, and more than one bat
species can be infected by the same coronavirus. The
consistent detection of bat-CoV-HKU2 and bat-SARS-CoV in
Chinese horseshoe bats over the 2-year study period from both
Hong Kong and Guangdong suggested that this bat species is
an established reservoir for both viruses which belonged to two
different groups. Chinese horseshoe bat, under the family
Rhinolophidae, is a common insectivorous species found in
Hong Kong and China. Apart from Rhinolophus sinicus, R.
ferrumequinum, another horseshoe bat species found in China,
has also been found to harbor both group 1 and group 2
coronaviruses (Tang et al., 2006). Therefore, it is likely that
bats, especially members of Rhinolophidae, can be infected by
both group 1 and group 2 coronaviruses, a situation similar to
humans who can be infected by group 1 (HCoV-229E and
HCoV-NL63) and group 2 (SARS-CoV, HCoV-OC43, and
CoV-HKU1) coronaviruses. As for the infection of more than
one bat species by the same coronavirus, SARS-CoV-like
viruses have been detected in at least three different species of
Rhinolophidae in China (Li et al., 2005b). More extensive
surveillance for coronaviruses in different species of horseshoe
bats would shed light on the role of this bat family in the
ecology and evolution of coronaviruses.Materials and methods
Sample collection
Chinese horseshoe bats (R. sinicus) were captured from
various locations in Hong Kong and in the Guangdong province
of Southern China over a 2-year period (April 2004 to April
2006). Their respiratory and alimentary specimens were
collected using procedures described previously (Lau et al.,
2005; Yob et al., 2001). All specimens were placed in viral
transport medium before transportation to the laboratory for
RNA extraction.
RNA extraction
Viral RNAwas extracted from the respiratory and alimentary
specimens using QIAamp Viral RNA Mini Kit (QIAgen,
Hilden, Germany). The RNAwas eluted in 50 μl of AVE buffer
and was used as the template for RT-PCR.
RT-PCR for coronaviruses and DNA sequencing
Coronavirus screening was performed by amplifying a 440-
bp fragment of the RNA-dependent RNA polymerase (RdRp)
gene of coronaviruses using conserved primers (5′-GGTTGGG-
ACTATCCTAAGTGTGA-3′ and 5′-CCATCATCAGATAGA-
ATCATCATA-3′) designed by multiple alignments of the
nucleotide sequences of available RdRp genes of known
coronaviruses (Woo et al., 2005a). Reverse transcription was
performed using the SuperScript III kit (Invitrogen, San Diego,
CA, USA). The PCR mixture (25 μl) contained cDNA, PCR
buffer (10 mMTris–HCl pH 8.3, 50mMKCl, 3mMMgCl2, and
0.01% gelatin), 200 μM of each dNTPs, and 1.0 U Taq
polymerase (Applied Biosystem, Foster City, CA, USA). The
mixtures were amplified in 60 cycles of 94 °C for 1 min, 48 °C
for 1 min, and 72 °C for 1 min and a final extension at 72 °C for
10 min in an automated thermal cycler (Applied Biosystem,
Foster City, CA, USA). Standard precautions were taken to
avoid PCR contamination and no false-positive was observed in
negative controls.
The PCR products were gel-purified using the QIAquick gel
extraction kit (QIAgen, Hilden, Germany). Both strands of the
PCR products were sequenced twice with an ABI Prism 3700
DNA Analyzer (Applied Biosystems, Foster City, CA, USA),
using the two PCR primers. The sequences of the PCR products
were compared with known sequences of the RdRp genes of
coronaviruses in the GenBank database.
Viral culture
Three of the samples positive for bat-CoV HKU2 were
cultured in LLC-Mk2 (rhesus monkey kidney), MRC-5 (human
lung fibroblast), FRhK-4 (rhesus monkey kidney), Huh-7.5
(human hepatoma), Vero E6 (African green monkey kidney),
HRT-18 (colorectal adenocarcinoma) cell lines and primary
kidney epithelium and lung fibroblast cells derived from a
Chinese horseshoe bat.
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Four complete genomes of bat-CoV HKU2 detected in the
present study were amplified and sequenced using the RNA
extracted from the alimentary specimens as templates. The
RNA was converted to cDNA by a combined random-priming
and oligo(dT) priming strategy. As the initial results revealed
that they were group 1 coronaviruses, the cDNAwas amplified
by degenerate primers designed by multiple alignment of the
genomes of human coronavirus 229E (HCoV-229E) (GenBank
accession no. NC_002645), porcine epidemic diarrhea virus
(PEDV) (GenBank accession no. NC_003436), porcine trans-
missible gastroenteritis virus (TGEV) (GenBank accession no.
NC_002306), feline infectious peritonitis virus (FIPV) (Gen-
Bank accession no. AY994055), and HCoV-NL63 (GenBank
accession no. NC_005831), and additional primers covering the
original degenerate primer sites were designed from the results
of the first and subsequent rounds of sequencing. These primer
sequences are available on request. The 5′ ends of the viral
genomes were confirmed by rapid amplification of cDNA ends
using the 5′/3′ RACE kit (Roche, Germany). Sequences were
assembled and manually edited to produce final sequences of
the viral genomes.
Genome analysis
The nucleotide sequences of the genomes and the deduced
amino acid sequences of the open reading frames (ORFs) were
compared to those of other coronaviruses. Phylogenetic tree
construction was performed using neighbor joining method
with ClustalX 1.83. Protein family analysis was performed
using PFAM and InterProScan (Apweiler et al., 2001; Bateman
et al., 2002). Prediction of transmembrane domains was
performed using TMHMM (Sonnhammer et al., 1998).
Estimation of synonymous and non-synonymous substitution
rates
The number of synonymous substitutions per synonymous
site, Ks, and the number of non-synonymous substitutions per
non-synonymous site, Ka, for each coding region were
calculated using the Nei-Gojobori method (Jukes-Cantor) in
MEGA 3.1 (Kumar et al., 2004). Six pairwise comparisons on
the four strains of bat-CoV HKU2 were performed for each
coding region.
Recombination analysis
Sliding window analysis was used to detect possible
recombination, using a nucleotide alignment of the genome
sequences of the four strains of bat-CoV HKU2 and bat-SARS-
CoV (GenBank accession no. DQ022305) generated by
ClustalX version 1.83 and edited manually. Bootscan analysis
was performed using Simplot version 3.5.1 (Lole et al., 1999)
(F84 model; window size, 1000 bp; step, 200 bp) with the
genome sequence of SARS-CoV (GenBank accession no.
NC_004718) as a query.Nucleotide sequence accession numbers
The nucleotide sequences of the four genomes of bat-CoV
HKU2 have been lodged within the GenBank sequence
database under accession no. EF203064 to EF203067.
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